top of page
TigaTx Announces up to $35.5M in Funding from ARPA-H and NIH Awards to Advance First-in-Class Engineered IgA Monoclonal Antibody for Cancer and Infectious Diseases (biospace.com)
Dec 19, 2024
This is placeholder text. To change this content, double-click on the element and click Change Content.
bottom of page